Corporate Sites
https://www.exelixis.com/
Contact for CT:
Paula Belekewicz
Professional Territory Manager
860-214-6669
pbelekewicz@exelixis.com
Important News and Information
Exelixis Announces Initiation of the STELLAR-305 Phase 2/3 Pivotal Trial Evaluating Zanzalintinib in Combination with Pembrolizumab in Patients with Previously Untreated Recurrent or Metastatic Head and Neck Cancer 12/04/2023
Exelixis announces first 100 patients enrolled in Phase 3 02/25/2020
c/o Dawn Holcombe
dawnho@aol.com
33 Woodmar Circle South Windsor, CT 06074 (860) 305-4510
Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds